Genovac Antibody Discovery LLC

Fargo, ND

UEI
XLZUCKG5TEJ5
CAGE
8TQ91
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
NAICS codes registered in SAM.gov
Corporate family
  • Genovac Antibody Discovery LLC XLZUCKG5TEJ5
SAM.gov registration date
Physical address
1810 NDSU Research Cir N Ste B, Fargo, ND 58102, USA
Website
genovac.com
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Genovac Antibody Discovery LLC's 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Human monoclonal antibody development Contract · HT942524P0103 Defense Health Agency $120,000
Generation of monoclonal antibodies Contract · HT942523P0030 Defense Health Agency $84,721

Quick answers

What is Genovac Antibody Discovery LLC's UEI?

Genovac Antibody Discovery LLC's Unique Entity ID (UEI) in SAM.gov is XLZUCKG5TEJ5.

What is Genovac Antibody Discovery LLC's CAGE code?

Genovac Antibody Discovery LLC's CAGE code is 8TQ91.

What is Genovac Antibody Discovery LLC's primary NAICS code?

Genovac Antibody Discovery LLC's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Where is Genovac Antibody Discovery LLC located?

Genovac Antibody Discovery LLC's physical address in SAM.gov is 1810 NDSU Research Cir N Ste B, Fargo, ND 58102, USA.

Is Genovac Antibody Discovery LLC registered in SAM.gov?

Yes. Genovac Antibody Discovery LLC's SAM.gov registration is active through July 16, 2027.

What is Genovac Antibody Discovery LLC's most recent federal award?

Genovac Antibody Discovery LLC's most recent federal contract award is Human monoclonal antibody development (HT942524P0103), from Defense Health Agency, on September 6, 2024.

On GovTribe

See Genovac Antibody Discovery LLC's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login